Effects of different fatty acids composition of phosphatidylcholine on brain function of dementia mice induced by scopolamine

Lipids in Health and Disease

Volumn 15, Issue 1, 2016, Pages

  Zhou, Miao Miao ^a   Xue, Yong ^a   Sun, Shu Hong ^b   Wen, Min ^a   Li, Zhao Jie ^a   Xu, Jie ^a   Wang, Jing Feng ^a   Yanagita, Teruyoshi ^c   Wang, Yu Ming ^a   Xue, Chang Hu ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

^c NISHIKYUSHU UNIVERSITY   (Japan)

Author keywords

Antioxidant; Cholinergic system; Long chain n 3 polyunsaturated fatty acids; Phosphatidylcholine

Indexed keywords

ACETYLCHOLINESTERASE; AMINE OXIDASE (FLAVIN CONTAINING); MALONALDEHYDE; PHOSPHATIDYLCHOLINE; SUPEROXIDE DISMUTASE; OMEGA 3 FATTY ACID; SCOPOLAMINE BROMIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DEMENTIA; ENZYME ACTIVITY; FATTY ACID ANALYSIS; HIPPOCAMPUS; LIPID COMPOSITION; MALE; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; OXIDATIVE STRESS; WHITE MATTER; ANIMAL; BAGG ALBINO MOUSE; BRAIN; CHEMICALLY INDUCED; CHEMISTRY; DECAPODIFORMES; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; EGG YOLK; MAZE TEST; METABOLISM; SEA CUCUMBER;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; DECAPODIFORMES; DEMENTIA; DISEASE MODELS, ANIMAL; EGG YOLK; FATTY ACIDS, OMEGA-3; MALE; MAZE LEARNING; MICE, INBRED BALB C; MONOAMINE OXIDASE; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES; SCOPOLAMINE HYDROBROMIDE; SEA CUCUMBERS;

EID: 85007564020     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-016-0305-5     Document Type: Article

References (58)

1. Huang YD, Mucke L. Alzheimer Mechanisms and Therapeutic Strategies. Cell. 2012;148(6):1204-22. doi:10.1016/j.cell.2012.02.040.
2. Wimo A, Jonsson L, Bond J, Prince M, Winblad B, Alzheimer Disease I: The worldwide economic impact of dementia 2010. Alzheimers Dement 2013;9: 1-11 e13.
3. Selkoe DJ. Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol. 2004;6(11):1054-61.
4. Yan C, Meizeng Z, Qin L, Yunliang G, Wei D, Lihua W, et al. Interfering effect and mechanism of neuregulin on experimental dementia model in rats. Behav Brain Res. 2011;222(2):321-5.
5. Chauhan V, Chauhan A. Oxidative stress in Alzheimer's disease. Pathophysiology. 2006;13(3):195-208.
6. Kay C, Harper DN, Hunt M. Differential effects of MDMA and scopolamine on working versus reference memory in the radial arm maze task. Neurobiology of Learning & Memory. 2010;93(2):151-6.
7. Ohba T, Yoshino Y, Ishisaka M, Abe N, Tsuruma K, Shimazawa M, et al. Japanese Huperzia serrata extract and the constituent, huperzine A, ameliorate the scopolamine-induced cognitive impairment in mice. Biosci Biotechnol Biochem. 2015;79(11):1838-44. doi:10.1080/09168451.2015.1052773.
8. Yang P, Miaoyu LI. Advances in the Research on the Etiologies and Therapeutic Drugs of AD. J Shanxi University. 2004;27(4):427-31.
9. Han XQ, Liu CH, Xue Y, Wang JF, Xue CH, Yanagita T, et al. Long-Term fatty liver-induced insulin resistance in orotic acid-induced nonalcoholic fatty liver rats. Biosci Biotech Bioch. 2016;80(4):735-43. doi:10.1080/09168451.2015.1123608.
10. Liu XF, Xue Y, Liu CH, Lou QM, Wang JF, Yanagita T, et al. Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids Health Dis. 2013;12:Artn 109doi:10.1186/1476-511x-12-109.
11. Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, et al. Nutraceuticals and dyslipidaemia: Beyond the common therapeutics. J Funct Foods. 2014;6:11-32. doi:10.1016/j.jff.2013.12.006.
12. Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR. Plasma n - 3 fatty acids and the risk of cognitive decline in older adults: The Atherosclerosis Risk in Communities Study. Am J Clin Nutr. 2007;85(4):1103-11.
13. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA. 2010;304(17):1903-11.
14. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev. 2007;12(3):207.
15. Battino M, Bullon P, Wilson M, Newman H. Oxidative injury and inflammatory periodontal diseases: The challenge of anti-oxidants to free radicals and reactive oxygen species. Critical Reviews in Oral Biology & Medicine. 1999;10(4): 458-76.
16. Saw CLL, Huang Y, Kong A-N. Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid. Biochem Pharmacol. 2010; 79(3):421-30.
17. Palacios-Pelaez R, Lukiw WJ, Bazan NG. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol Neurobiol. 2010;41(2-3):367-74.
18. Su H-M. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J Nutr Biochem. 2010;21(5):364-73.
19. J-w WANG, C-z WEN, Q-w LIU. Study on the Effect of Several Food Additives on Anti-Aging and Improving the Bread [J]. Grain Processing. 2010;1:021.
20. Suzuki S, Yamatoya H, Sakai M, Kataoka A, Furushiro M, Kudo S. Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats. J Nutr. 2001;131(11):2951-6.
21. Higgins JP, Flicker L: Lecithin for dementia and cognitive impairment. Cochrane Database Syst Rev. 2000;CD001015.
22. Lieber CS, Robins Sj Fau-Li J, Li J Fau-DeCarli LM, DeCarli Lm Fau-Mak KM, Mak Km Fau-Fasulo JM, Fasulo Jm Fau-Leo MA et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology. 1994;106:152-159.
23. El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary EE-DS. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav. 2003;76(3):525-33.
24. Min AY, Doo CN, Son EJ, Sung NY, Lee KJ, Sok DE, et al. N-palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice. Chem Biol Interact. 2015;242:153-162.
25. Kwon SH, Lee Hk Fau-Kim J-A, Kim Ja Fau-Hong S-I, Hong Si Fau-Kim H-C, Kim Hc Fau-Jo T-H, Jo Th Fau-Park Y-I et al. Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-Acetylcholinesterase and anti-oxidative activities in mice. Eur J Pharmacol. 2010;649:210-217.
26. Risner M, Saunders A, Altman J, Ormandy G, Craft S, Foley I, et al. Efficacy of rosiglitazone in a genetically defined population with mild-To-moderate Alzheimer's disease. Pharmacogenomics J. 2006;6(4):246-54.
27. Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, et al. The A4 study: stopping AD before symptoms begin? Science translational medicine. 2014;6(228):22813.
28. Liu X, Xu J, Xue Y, Gao Z, Li Z, Leng K, et al. Sea cucumber cerebrosides and long-chain bases from Acaudina molpadioides protect against high fat diet-induced metabolic disorders in mice. Food Funct. 2015. doi:10.1039/c5fo00602c.
29. Zhang B, Xue C, Hu X, Xu J, Li Z, Wang J, et al. Dietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexis in rats. Lipids Health Dis. 2012;11(1):48.
30. WANG J, LIU C, REN B, WANG Y, XUE C. Effects of phospholipids with different fatty acid compositions on the digestive absorption of rats. China Oils and Fats. 2013;8:015.
31. Goverdhan P, Sravanthi A, Mamatha T. Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int J Alzheimers Dis. 2012;2012.
32. Gutierres JM, Carvalho FB, Schetinger MR, Rodrigues MV, Schmatz R, Pimentel VC, et al. Protective effects of anthocyanins on the ectonucleotidase activity in the impairment of memory induced by scopolamine in adult rats. Life Sci. 2012;91(23):1221-8.
33. Raut S, Bhadoriya SS, Uplanchiwar V, Mishra V, Gahane A, Jain SK. Lecithin organogel: A unique micellar system for the delivery of bioactive agents in the treatment of skin aging. Acta Pharm Sin B. 2012;2(1):8-15.
34. Farooqui AA, Farooqui T, Farooqui A. Generation of reactive oxygen species in the brain: signaling for neural cell survival or suicide. Oxidative Stress in Vertebrates and Invertebrates: Molecular Aspects of Cell Signaling. 2012:3-17.
35. Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res. 1999;40(3):211-25.
36. Hasselmo ME. The role of acetylcholine in learning and memory. Curr Opin Neurobiol. 2006;16(6):710-5.
37. Atack Jr. Fau-Perry EK, Perry Ek Fau-Bonham JR, Bonham Jr. Fau-Candy JM, Candy Jm Fau-Perry RH, Perry RH. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochemistry. 1986;47:263-277.
38. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, et al. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron. 1996;16(4):881-91.
39. Schliebs R, Arendt T. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm. 2006;113(11): 1625-44.
40. Nordberg A, Svensson A-L. Cholinesterase inhibitors in the treatment of Alzheimer's disease. Drug Saf. 1998;19(6):465-80.
41. Coyle JT, Price DL, DeLong MR. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science. 1983;219(4589):1184-90.
42. Fan Y-Y, McMurray DN, Ly LH, Chapkin RS. Dietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J Nutr. 2003;133(6):1913-20.
43. Jezek P, Hlavatá L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol. 2005;37(12):2478-503.
44. Harper ME, Bevilacqua L, Hagopian K, Weindruch R, Ramsey J. Ageing, oxidative stress, and mitochondrial uncoupling. Acta Physiol Scand. 2004; 182(4):321-31.
45. Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol. 2007;83(1):84-92.
46. Wu F-J, Xue Y, Liu X-F, Xue C-H, Wang J-F, Du L, et al. The protective effect of eicosapentaenoic acid-enriched phospholipids from sea cucumber Cucumaria frondosa on oxidative stress in PC12 cells and SAMP8 mice. Neurochem Int. 2014;64:9-17.
47. Safarinejad MR, Hosseini SY, Dadkhah F, Asgari MA. Relationship of omega-3 and omega-6 fatty acids with semen characteristics, and anti-oxidant status of seminal plasma: A comparison between fertile and infertile men. Clin Nutr. 2010;29(1):100-5.
48. Sherif F, Gottfries C, Alafuzoff I, Oreland L. Brain gamma-Aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease. J Neural Transm Park Dis Dement Sect. 1992;4(3):227-40.
49. Gaweska H, Fitzpatrick PF. Structures and mechanism of the monoamine oxidase family. Biomolecular Concepts. 2011;2(5):365-77.
50. Delgado PL, Price LH, Miller HL, Salomon RM, Licinio J, Krystal J, et al. Rapid serotonin depletion as a provocative challenge test for patients with major depression: Relevance to antidepressant action and the neurobiology of depression. Psychopharmacol Bull. 1991.
51. Cai Z. Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer's disease (Review). Mol Med Rep. 2014;9(5):1533-41.
52. Hroudová J, Singh N, Fišar Z, Ghosh KK. Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism. Eur J Med Chem. 2016.
53. Saada HN, Said UZ, Mahdy EM, Elmezayen HE, Shedid SM. Fish oil omega-3 fatty acids reduce the severity of radiation-induced oxidative stress in the rat brain. Int J Radiat Biol. 2014;90(12):1179-83.
54. Innis SM. Impact of maternal diet on human milk composition and neurological development of infants. Am J Clin Nutr. 2014;99(3):734S-41S.
55. Ma Q, Wang J-f, Wang Y-m, Li X-l, Fu J, Xue C-H. Effects of DHA-PC on intelligence in dementia mice induced by scopolamine. Periodical of Ocean University of China (Natural Science). 2009;S1:69-72.
56. Wang Y-M, Li J-z, Xue Y, Li Z-J, Wang J-F, Xue C-H. Effects of different dietary phospholipids on lipid metabolism and brain phospholipids fatty acid composition in rats. China Oils and Fats. 2012;37(2):31-4.
57. Boudrault C, Bazinet RP, Ma DW. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J Nutr Biochem. 2009;20(1):1-10.
58. Connor WE. Importance of n - 3 fatty acids in health and disease. Am J Clin Nutr. 2000;71(1):171S-5S.